ProCE Banner Activity

CE / CME

Building a Comprehensive Obesity Care Clinic

Video

Experts provide practical suggestions for incorporating obesity management into clinical practice and designing a comprehensive obesity care clinic.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurses: 1.00 Nursing contact hour

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: June 15, 2023

Expiration: June 14, 2024

Share

Faculty

Caroline Apovian

Caroline Apovian, MD

Member of the Faculty
Endocrinology, Diabetes, and Hypertension
Harvard Medical School
Co-Director
Center for Weight Management and Wellness
Brigham and Womens Hospital
Boston, Massachusetts

W. Scott Butsch

W. Scott Butsch, MD, MSc

Director of Obesity Medicine 
Bariatric and Metabolic Institute
Cleveland Clinic 
Cleveland, Ohio 

Daniel Zalinov

Daniel Zalinov, PA-C

Internal Medicine
Atrium Health
Charlotte, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner

Q Synthesis LLC

ProCE Banner

Target Audience

This activity is intended for a broad audience of interprofessional healthcare professionals who provide care, education, and counseling for patients with obesity including primary care physicians, nurse practitioners, physician associates/physician assistants, and pharmacists.

Program Learning Goal

The goal of this initiative is to increase the percentage of adults with obesity who receive guideline recommended obesity care by 15% among participating clinic sites by the conclusion of the project. This will be determined by a series of 4 quality measures. In addition, individual clinic teams participating in the project as QI teams will establish tailored process improvement goals in order to address their local gaps to improve care and patient outcomes.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Design a collaborative care initiative to improve long-term weight loss in patients with obesity

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Caroline Apovian, MD

Member of the Faculty
Endocrinology, Diabetes, and Hypertension
Harvard Medical School
Co-Director
Center for Weight Management and Wellness
Brigham and Womens Hospital
Boston, Massachusetts

Caroline Apovian, MD: consultant/advisor/speaker: Altimmune, Inc., Currax Pharmaceuticals, Gelesis, Srl., L-Nutra, Inc., NeuroBo Pharmaceuticals Inc., Novo Nordisk, Inc., Pain Script Corporation, ReShape Lifesciences Inc., Xeno Biosciences.

W. Scott Butsch, MD, MSc

Director of Obesity Medicine 
Bariatric and Metabolic Institute
Cleveland Clinic 
Cleveland, Ohio 

W. Scott Butsch, MD, MSc: consultant/advisor/speaker: Novo Nordisk.

Daniel Zalinov, PA-C

Internal Medicine
Atrium Health
Charlotte, North Carolina

Daniel Zalinov, PA-C, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC, ProCE, LLC, Practicing Clinicians Exchange, and Q Synthesis have no relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from June 15, 2023, through June 14, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC, Practicing Clinicians Exchange, and Q Synthesis. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hour awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Physician Assistants/Physician Associates Continuing Medical Education
Joint AccreditationClinical Care Options has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until  June 14, 2024. PAs should only claim credit commensurate with the extent of their participation.

 

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008176-9999-23-168-H01-P
Type of Activity: Application

Upon successfully completing the post-test with a score of 65 and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.